• Login
    JavaScript is disabled for your browser. Some features of this site may not work without it.
    Search 
    •   QMRO Home
    • Wolfson Institute of Preventive Medicine
    • Search
    •   QMRO Home
    • Wolfson Institute of Preventive Medicine
    • Search
    ‌
    ‌

    Browse

    All of QMROCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CommunityBy Issue DateAuthorsTitlesSubjects
    ‌
    ‌

    Administrators only

    Login
    ‌
    ‌

    Discover

    AuthorCuzick, J (15)Howell, A (11)Brentnall, AR (10)Sestak, I (9)Duffy, SW (8)Evans, DG (6)Harkness, EF (6)Dowsett, M (5)Astley, S (4)Sampson, S (4)... View MoreSubject
    Breast cancer (30)
    Chemoprevention (4)Mammography (4)Prediction (4)Screening (4)Breast density (3)Early detection (3)Mammographic density (3)Prevention (3)Tamoxifen (3)... View MoreDate Issued2022 (1)2021 (1)2020 (6)2019 (5)2018 (9)2017 (6)2016 (1)2015 (1)
    ‌
    ‌

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Search

    Show Advanced FiltersHide Advanced Filters

    Filters

    Use filters to refine the search results.

    Now showing items 1-10 of 30

    • Sort Options:
    • Relevance
    • Title Asc
    • Title Desc
    • Issue Date Asc
    • Issue Date Desc
    • Results Per Page:
    • 5
    • 10
    • 20
    • 40
    • 60
    • 80
    • 100
    Thumbnail

    Novel 18-gene signature for predicting relapse in ER-positive, HER2-negative breast cancer. 

    Buus, R; Yeo, B; Brentnall, AR; Klintman, M; Cheang, MCU; Khabra, K; Sestak, I; Gao, Q; Cuzick, J; Dowsett, M (2018-09-04)
    BACKGROUND: Several prognostic signatures for early oestrogen receptor-positive (ER+) breast cancer have been established with a 10-year follow-up. We tested the hypothesis that signatures optimised for 0-5-year and 5-10-year ...
    Thumbnail

    Rapid review of evaluation of interventions to improve participation in cancer screening services 

    Duffy, SW; Myles, JP; Maroni, R; Mohammad, A (2017-09)
    Thumbnail

    Uptake of breast cancer preventive therapy in the UK: results from a multicentre prospective survey and qualitative interviews. 

    Hackett, J; Thorneloe, R; Side, L; Wolf, M; Horne, R; Cuzick, J; Smith, SG (2018-08)
    PURPOSE: Uptake of preventive therapy for women at increased breast cancer risk in England is unknown following the introduction of UK clinical guidelines in 2013. Preventive therapy could create socioeconomic inequalities ...
    Thumbnail

    Identifying Biomarkers to Select Patients with Early Breast Cancer Suitable for Extended Adjuvant Endocrine Therapy 

    Sestak, I (2017)
    Thumbnail

    Lifestyle behaviours and health measures of women at increased risk of breast cancer taking chemoprevention. 

    Pegington, M; Evans, DG; Howell, A; Donnelly, LS; Wiseman, J; Cuzick, JM; Harvie, MN (Lippincott, Williams & Wilkins, 2018-11-15)
    Women at increased breast cancer (BC) risk are eligible for chemoprevention. Healthy lifestyles are potentially important for these women to improve efficacy and minimise side effects of chemoprevention and reduce the risk ...
    Thumbnail

    HER2 status predicts for upfront AI benefit: A TRANS-AIOG meta-analysis of 12,129 patients from ATAC, BIG 1-98 and TEAM with centrally determined HER2 

    Bartlett, JMS; Ahmed, I; Regan, MM; Sestak, I; Mallon, EA; Dell'Orto, P; Thurlimann, B; Seynaeve, C; Putter, H; Van de Velde, CJH;... (2017-07)
    Thumbnail

    Breast cancer risk in a screening cohort of Asian and white British/Irish women from Manchester UK. 

    Evans, DG; Brentnall, AR; Harvie, M; Astley, S; Harkness, EF; Stavrinos, P; Donnelly, LS; Sampson, S; Idries, F; Watterson, D;... (2018-01-25)
    BACKGROUND: The differences between breast cancer risk factors in white British/Irish and Asian women attending screening in the UK are not well documented. METHODS: Between 2009-15 ethnicity and traditional breast cancer ...
    Thumbnail

    The impact of mammography screening programmes on incidence of advanced breast cancer in Europe: a literature review. 

    Broeders, MJM; Allgood, P; Duffy, SW; Hofvind, S; Nagtegaal, ID; Paci, E; Moss, SM; Bucchi, L (2018-09-03)
    BACKGROUND: Observational studies have reported conflicting results on the impact of mammography service screening programmes on the advanced breast cancer rate (ABCR), a correlation that was firmly established in randomized ...
    Thumbnail

    Letrozole-induced necrotising leukocytoclastic small vessel vasculitis: First report of a case in the UK. 

    Pathmarajah, P; Shah, K; Taghipour, K; Ramachandra, S; Thorat, MA; Chaudhry, Z; Patkar, V; Peters, F; Connor, T; Spurrell, E;... (2015)
    INTRODUCTION: Letrozole, an aromatase inhibitor, is a commonly used neo-adjuvant drug to treat hormone-sensitive breast cancer. There have been a few cases of aromatase inhibitor induced vasculitis but the first case of ...
    Thumbnail

    Prediction of chemotherapy benefit by EndoPredict in patients with breast cancer who received adjuvant endocrine therapy plus chemotherapy or endocrine therapy alone 

    SESTAK, IVANA; CUZICK, J; Martín, M; Dubsky, P; Kronenwett, R; Rojo, F; Filipits, M; Ruiz, A; Gradishar, W; Soliman, H;... (Springer US, 2019-04-30)
    PURPOSE: EndoPredict (EPclin) is a prognostic test validated to inform decisions on adjuvant chemotherapy to endocrine therapy alone for patients with oestrogen receptor-positive, HER2-negative breast cancer. Here, we ...
    • 1
    • 2
    • 3
    Twitter iconFollow QMUL on Twitter
    Twitter iconFollow QM Research
    Online on twitter
    Facebook iconLike us on Facebook
    • Site Map
    • Privacy and cookies
    • Disclaimer
    • Accessibility
    • Contacts
    • Intranet
    • Current students

    Modern Slavery Statement

    Queen Mary University of London
    Mile End Road
    London E1 4NS
    Tel: +44 (0)20 7882 5555

    © Queen Mary University of London.